In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Just 48 hours after NAR unveiled major revisions to its MLS policies, plaintiffs in the Michigan-based Hardy lawsuit moved to use those changes as evidence, arguing they prove NAR’s prior rules were anticompetitive. NAR denies any wrongdoing, but the case is quickly becoming a key test for whether MLS access should require Realtor membership — a question now echoing across multiple states and potentially reshaping how real estate professionals nationwide access the industry’s most essential tool.
Florida homeowners are now paying some of the highest insurance premiums in the country, with average costs topping $5,800 per year—nearly double the national average. Residents report skyrocketing rates, denied claims, and tough choices between costly coverage and financial risk. As frustration grows, lawmakers and consumer advocates are pushing new reforms aimed at increasing transparency, capping rate hikes, and protecting policyholders in one of the nation’s most volatile insurance markets.
Economic uncertainty, rapid AI adoption, tighter capital flows, and rising portfolio risk are reshaping the 2026 commercial real estate landscape. From shifting workforce patterns to a national housing attainability crisis, the industry is entering a data‑driven, fundamentals‑focused era—making adaptability, education, and tech literacy essential for real estate professionals.
Mortgage rates have climbed to 6.23 percent as investors grow doubtful that the Federal Reserve will deliver a rate cut in December. A soft but unclear jobs report and persistent inflation have pushed borrowing costs higher, reversing October’s brief relief in the housing market. Real estate and mortgage professionals should prepare clients for continued volatility as the Fed’s December meeting approaches.
After years of tight inventory, high mortgage rates, and sluggish sales, economists say 2026 is shaping up to be the turnaround real estate professionals have been waiting for. NAR projects a 14 percent jump in home sales, mortgage rates easing toward 6 percent, and buyer demand finally gaining momentum. While higher‑end homes are moving quickly, first‑time buyers continue to face affordability challenges, and price reductions are reappearing as sellers adjust to shifting conditions. For Florida agents, brokers, and newcomers, the stage is being set for a busy and opportunity‑rich year.
Florida’s average homeowner insurance premium has soared to $5,838 a year—almost $3,000 above the national average—pushing many residents to the financial brink. From tripled premiums to lowball claim payouts, homeowners are speaking out as frustration mounts. Some are even dropping coverage entirely. With more than 40% of claims closed without payment and policy cancellations at record levels, lawmakers are pushing for reforms, but political hurdles remain. The outcome could reshape Florida real estate, insurance, and mortgage markets for years to come.
